• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Cullinan Therapeutics Inc (NQ: CGEM )

    18.02 +0.41 (+2.33%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Aug 21, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Cullinan Therapeutics Inc

    < Previous 1 2 3 4 Next >
    Cullinan Oncology to Participate in Cowen’s 43rd Annual Health Care Conference
    From Cullinan Oncology, Inc.
    Via GlobeNewswire
    Week In Review: China Biopharmas Announce Three Out-Licensing Deals Totaling $2 Billion
    Jiangsu Hengrui Pharma out-licensed US rights for a novel small molecule EZH2 inhibitor in a $706 million agreement with Treeline Biosciences of Connecticut. Hengrui will receive an upfront payment of... 
    Via Talk Markets
    Cullinan Oncology Licenses U.S. Rights to the First Clinical-Stage B7H4 x 4-1BB Bispecific Immune Activator from Harbour BioMed
    From Cullinan Oncology, Inc.
    Via GlobeNewswire
    5 Value Stocks In The Healthcare Sector
    Via Benzinga
    Insiders Buy Around $15M Of 2 Stocks
    Although the Dow Jones dropped by around 350 points on Friday, there were a few notable insider trades. 
    Via Benzinga
    Short Volatility Alert: Cullinan Oncology
    On Monday, shares of Cullinan Oncology, Inc. (NASDAQ: CGEM) experienced volatile short activity. After the activity, the stock price went up at 2.45% to $10.88. The overall... 
    Via Benzinga
    Cullinan Oncology to Participate in the Guggenheim 5th Annual Oncology Conference and the SVB Securities Global Biopharma Conference
    From Cullinan Oncology, Inc.
    Via GlobeNewswire
    Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Cullinan Oncology, Inc.
    Via GlobeNewswire
    Cullinan Oncology Announces U.S. FDA Clearance of Investigational New Drug Application for CLN-978, a Novel T-Cell Engager for the Treatment of Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
    From Cullinan Oncology, Inc.
    Via GlobeNewswire
    Why Are Cullinan Oncology Shares Rising Today?
    Taiho Pharmaceutical Co Ltd will co-develop and co-commercialize Cullinan Oncology Inc (NASDAQ: CGEM) lead program, CLN-081/TAS6417. 
    Via Benzinga
    Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Cullinan Oncology, Inc.
    Via GlobeNewswire
    5 Value Stocks To Watch In The Healthcare Sector
    Via Benzinga
    Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Cullinan Oncology, Inc.
    Via GlobeNewswire
    Cullinan Oncology Lead Cancer Program Shows Confirmed ORR Of 41% In Lung Cancer Setting
    Cullinan Oncology Inc (NASDAQ: CGEM)  
    Via Benzinga
    Cullinan Oncology Provides Corporate Update and Reports Third Quarter 2022 Financial Results
    From Cullinan Oncology, Inc.
    Via GlobeNewswire
    Cullinan Oncology Announces the Appointment of David P. Ryan, M.D. to its Board of Directors
    From Cullinan Oncology, Inc.
    Via GlobeNewswire
    Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Cullinan Oncology, Inc.
    Via GlobeNewswire
    Cullinan Oncology to Participate in Upcoming Investor Conferences
    From Cullinan Oncology, Inc.
    Via GlobeNewswire
    Cullinan Oncology Significantly Increases Ownership Stake in its MICA Subsidiary which Holds Worldwide Rights to Clinical-Stage Novel Monoclonal Antibody CLN-619
    From Cullinan Oncology, Inc.
    Via GlobeNewswire
    Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Cullinan Oncology, Inc.
    Via GlobeNewswire
    A Look Into Healthcare Sector Value Stocks
    The Meaning Behind Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base... 
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    90 Biggest Movers From Yesterday
    Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) surged 70.5% to close at $0.1330 on Thursday after declining 9% on Wednesday. Allena Pharmaceuticals recently reported a $2.8 million registered... 
    Via Benzinga
    Mid-Afternoon Market Update: Nasdaq Down 200 Points; Dutch Bros Shares Plunge
    U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping more than 200 points on Thursday. 
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    Executives Buy Around $15M Of 4 Stocks
    Although U.S. stocks closed sharply lower on Tuesday, there were a few notable insider trades. 
    Via Benzinga
    The Daily Biotech Pulse: Sanofi-IGM Ink Antibody Drug Collaboration; NeoGenomics Sinks On CEO Departure, Q1 Warning; Decision Day For Akebia
    Here's a roundup of top developments in the biotech space over the last 24 hours: 
    Via Benzinga
    58 Stocks Moving In Thursday's Mid-Day Session
    Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 102.6% to $0.1580 after declining 9% on Wednesday. Allena Pharmaceuticals recently reported a $2.8 million registered direct offering. 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Friday
    On Friday, 111 companies set new 52-week lows. Interesting Points From Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was Citigroup (... 
    Via Benzinga
    < Previous 1 2 3 4 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.